The ELG Analysis of Glucose a Correlational to Blood Glucose Assay

NAEnrolling by invitationINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 11, 2021

Primary Completion Date

October 31, 2025

Study Completion Date

November 30, 2025

Conditions
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventions
DEVICE

ELG

"The effectiveness of ELG to standardized blood test methods (fingerstick) and comparison to AlcNOW + (or equivalence) and of laboratory test results.~Human subject requirements during ELG study will not challenge diabetics or non-diabetics glycemic event. For example, diabetes type 1, the subject will not have to adjust their insulin or glucose. For type 2 diabetes, the subject will not have to adjust their oral hypoglycemic agent or glucose, as well."

Trial Locations (1)

72764

Rouse Family Medical Clinic, Springdale

All Listed Sponsors
lead

XP Technology, LLC

OTHER